Drug:
Reaction: DRUG HYPERSENSITIVITY
20250101 - 20251231
No. 701 - 800
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
701 | 25016988 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, |
||||
702 | 25016990 |
US |
1 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, DIAZEPAM, |
||||
703 | 25016991 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, DIVALPROEX SODIUM, |
||||
704 | 25016992 |
US |
1 | |
Drug hypersensitivity, Feeling abnormal, |
||||
LEVETIRACETAM, DIVALPROEX SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, GABAPENTIN, |
||||
705 | 25016993 |
US |
||
Drug hypersensitivity, |
||||
LEVETIRACETAM, |
||||
706 | 25016997 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, |
||||
707 | 25017000 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, |
||||
708 | 25017001 |
US |
1 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, |
||||
709 | 25017002 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, ALPRAZOLAM, ESOMEPRAZOLE MAGNESIUM, LEVOTHYROXINE SODIUM, NAPROXEN, NAPROXEN SODIUM, POTASSIUM CHLORIDE, TIZANIDINE HYDROCHLORIDE, |
||||
710 | 25017003 |
US |
1 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, DIVALPROEX SODIUM, OXCARBAZEPINE, |
||||
711 | 25017004 |
US |
1 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, |
||||
712 | 25017008 |
US |
1 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, TOPIRAMATE, TOPIRAMATE SPINKLE, CLONAZEPAM, RIZATRIPTAN, OXCARBAZEPINE, |
||||
713 | 25017009 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, ZONISAMIDE, CLONAZEPAM, |
||||
714 | 25017011 |
US |
49 | 2 |
Drug hypersensitivity, Agitation, |
||||
LEVETIRACETAM, DIVALPROEX SODIUM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, MELATONIN, GABAPENTIN, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, |
||||
715 | 25017012 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, BRIVARACETAM, LACOSAMIDE, MIDAZOLAM, CETIRIZINE HYDROCHLORIDE, AZATHIOPRINE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, CYANOCOBALAMIN, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), FAMOTIDINE, FERROUS SULFATE, FOLIC ACID, LORAZEPAM, LORAZEPAM, LOSARTAN POTASSIUM, MONTELUKAST SODIUM, OXCARBAZEPINE, PANTOPRAZOLE SODIUM, PROPRANOLOL HYDROCHLORIDE, |
||||
716 | 25017013 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, CLONIDINE HYDROCHLORIDE, CLONIDINE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SIMVASTATIN, CARVEDILOL, LACOSAMIDE, GABAPENTIN, AMLODIPINE BESYLATE, OXYBUTYNIN, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, NITROGLYCERIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
717 | 25017023 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, |
||||
718 | 25017034 |
US |
1 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, |
||||
719 | 25017039 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, LEVOTHYROXINE, |
||||
720 | 25017041 |
US |
1 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, DIVALPROEX SODIUM, FOLIC ACID, OLANZAPINE, LACOSAMIDE, |
||||
721 | 25017043 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, CLONAZEPAM, |
||||
722 | 25017044 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, NAPROXEN, NAPROXEN SODIUM, DIAZEPAM, ZONISAMIDE, |
||||
723 | 25017045 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, TOPIRAMATE, TOPIRAMATE SPINKLE, BRIVARACETAM, CLOBAZAM, ZONISAMIDE, |
||||
724 | 25017046 |
US |
1 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, AMLODIPINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, STANDARDIZED SENNA CONCENTRATE, GABAPENTIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
725 | 25017048 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, AMOXICILLIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, DICLOFENAC, DICLOFENAC SODIUM, GALCANEZUMAB-GNLM, ERGOCALCIFEROL, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, LISINOPRIL, LISINOPRIL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MONTELUKAST, PROMETHAZINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ROPINIROLE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
726 | 25017050 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, |
||||
727 | 25017051 |
US |
1 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, |
||||
728 | 25017056 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, GABAPENTIN, MELOXICAM, TOPIRAMATE, ALPRAZOLAM, AMLODIPINE, HYDROXYZINE PAMOATE, TIZANIDINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, |
||||
729 | 25017065 |
US |
59 | 2 |
Drug hypersensitivity, Unresponsive to stimuli, Nausea, Vomiting, Drug hypersensitivity, Unresponsive to stimuli, Blood pressure systolic increased, |
||||
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, DOXERCALCIFEROL, IRON SUCROSE, |
||||
730 | 25017602 |
CA |
65 | 2 |
Pneumonia, Vomiting, Asthma, Dyspnoea, Oedema, Drug hypersensitivity, Wheezing, |
||||
AMINOPHYLLINE, AMLODIPINE, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, CLONAZEPAM, ROSUVASTATIN, HYDROMORPHONE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, PREDNISOLONE SODIUM PHOSPHATE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, MONTELUKAST SODIUM, TRAMADOL HYDROCHLORIDE, |
||||
731 | 25017929 |
US |
37 | 1 |
Mycoplasma infection, Surgery, Hypertension, Drug hypersensitivity, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, SOLRIAMFETOL, AMPHETAMINE, CETIRIZINE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, CYCLOBENZAPRINE, |
||||
732 | 25018019 |
US |
2 | |
Drug hypersensitivity, |
||||
METHADONE, |
||||
733 | 25018082 |
60 | 2 | |
Angioedema, Drug hypersensitivity, |
||||
LISINOPRIL, |
||||
734 | 25018273 |
US |
14 | 2 |
Osteonecrosis, Dyspnoea, Abdominal pain, Bone density decreased, Drug hypersensitivity, Lymphadenopathy, Urine analysis abnormal, Abdominal pain upper, Illness, Off label use, |
||||
VOXELOTOR, VOXELOTOR, HYDROXYUREA, |
||||
735 | 25018494 |
BR |
2 | |
Pneumonia, Pulmonary embolism, Breast cancer, Bone cancer, Arthralgia, Bone pain, Cough, Pulmonary thrombosis, Confusional state, Hypoacusis, Head discomfort, Memory impairment, Condition aggravated, Malaise, Epistaxis, Alopecia, Negative thoughts, Drug hypersensitivity, Pruritus, Skin discolouration, Bone disorder, Fall, Limb injury, Lung disorder, Sleep disorder, Ill-defined disorder, Laziness, Balance disorder, Decreased appetite, Asthenia, Incorrect dose administered, Drug ineffective, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, PANTOPRAZOLE, PANTOPRAZOLE, RIVAROXABAN, |
||||
736 | 25019142 |
US |
2 | |
Drug hypersensitivity, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
737 | 25019148 |
US |
63 | 2 |
Myocardial infarction, Drug hypersensitivity, |
||||
INTERFERON BETA-1B, FINGOLIMOD HCL, |
||||
738 | 25019422 |
ES |
32 | 2 |
Stress cardiomyopathy, Myocardial ischaemia, Cardiac failure congestive, Cardiogenic shock, Kounis syndrome, Chest pain, Anaphylactic reaction, Drug hypersensitivity, Dyspnoea, Vomiting, Urticaria, Adrenal disorder, |
||||
RANITIDINE, |
||||
739 | 25019727 |
US |
2 | |
Blepharitis, Drug hypersensitivity, |
||||
TAPINAROF, |
||||
740 | 25019792 |
US |
1 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, |
||||
741 | 25019814 |
CN |
56 | 1 |
Drug hypersensitivity, Rash, Tenderness, |
||||
CYTARABINE, AVAPRITINIB, |
||||
742 | 25019829 |
US |
68 | 2 |
Urticaria, Drug hypersensitivity, |
||||
RIMEGEPANT SULFATE, |
||||
743 | 25019934 |
SG |
8 | 2 |
Acute respiratory distress syndrome, Product use in unapproved indication, Candida infection, Drug hypersensitivity, Mediastinitis, Subcutaneous emphysema, Pneumonitis, Pneumomediastinum, Pneumothorax, Respiratory failure, Pulmonary toxicity, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, METHYLPREDNISOLONE, MICAFUNGIN, MICAFUNGIN SODIUM, METRONIDAZOLE, METRONIDAZOLE TOPICAL, CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
744 | 25020116 |
US |
2 | |
Drug hypersensitivity, |
||||
DESVENLAFAXINE SUCCINATE, |
||||
745 | 25020142 |
US |
44 | |
Drug hypersensitivity, |
||||
TOFACITINIB, |
||||
746 | 10264566 |
US |
7 | 2 |
Ear tube insertion, Otorrhoea, Cough, Drug hypersensitivity, Urticaria, Respiratory syncytial virus infection, Ear infection, Exposure via breast milk, |
||||
ETANERCEPT, ETANERCEPT, ACYCLOVIR, |
||||
747 | 25011595 |
US |
2 | |
Drug hypersensitivity, |
||||
BUSPIRONE HYDROCHLORIDE, CELECOXIB, GABAPENTIN, ASIAN GINSENG, MAGNESIUM, ELAGOLIX, FLUOXETINE HYDROCHLORIDE, SUMATRIPTAN SUCCINATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, ERGOCALCIFEROL, |
||||
748 | 25012080 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Pneumonia, Vomiting, Wheezing, Dyspnoea, Oedema, |
||||
AMLODIPINE, CLONAZEPAM, FOLIC ACID, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, RISEDRONATE SODIUM, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, ROPIVACAINE HYDROCHLORIDE, AMINOPHYLLINE, ROSUVASTATIN, OMALIZUMAB, PREDNISOLONE SODIUM PHOSPHATE, RITUXIMAB, MONTELUKAST SODIUM, |
||||
749 | 25012111 |
US |
60 | 2 |
Drug hypersensitivity, Abdominal pain, Diarrhoea, |
||||
TIRZEPATIDE, |
||||
750 | 25012182 |
US |
2 | |
Productive cough, Drug hypersensitivity, Asthma, Muscle spasms, Eye disorder, Pleural thickening, Malaise, |
||||
METOPROLOL TARTRATE, METOPROLOL, METHIMAZOLE, |
||||
751 | 25012515 |
CA |
76 | 1 |
Diarrhoea haemorrhagic, Dyspnoea, Fatigue, Abdominal pain upper, Drug hypersensitivity, Hypoaesthesia, Paraesthesia, |
||||
AVACOPAN, |
||||
752 | 25012674 |
IT |
46 | 2 |
Drug hypersensitivity, Flushing, Face oedema, Dyspnoea, |
||||
LANSOPRAZOLE, AMOXICILLIN, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
753 | 25013215 |
GB |
47 | 2 |
Suicidal ideation, Depressed mood, Vulvovaginal pain, Vulvovaginal candidiasis, Dysuria, Drug hypersensitivity, Complication of device removal, |
||||
LEVONORGESTREL, |
||||
754 | 25013417 |
DE |
39 | 2 |
Drug hypersensitivity, Drug eruption, Fixed eruption, Palpitations, Blood pressure decreased, Dizziness, |
||||
CEFUROXIME, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
755 | 25013625 |
US |
2 | |
Drug hypersensitivity, |
||||
LEVETIRACETAM, |
||||
756 | 25013704 |
US |
||
Drug hypersensitivity, Rash, Pruritus, Skin disorder, |
||||
BRIVARACETAM, LEVETIRACETAM, |
||||
757 | 25013743 |
US |
2 | |
Drug hypersensitivity, Pyrexia, |
||||
LEVETIRACETAM, LEVOTHYROXINE, |
||||
758 | 25013763 |
US |
2 | |
Drug hypersensitivity, Lethargy, Anaemia, Urticaria, Pruritus, Anger, Catatonia, |
||||
LEVETIRACETAM, ERGOCALCIFEROL, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, CALCIUM, GABAPENTIN, TIZANIDINE, MAGNESIUM OXIDE, CITRIC ACID, BETAINE, SORBITOL, |
||||
759 | 25013926 |
US |
69 | 2 |
Pollakiuria, Drug hypersensitivity, |
||||
TIRZEPATIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
760 | 25014144 |
IT |
58 | 2 |
Drug hypersensitivity, Skin reaction, Oxygen saturation decreased, Hypertension, |
||||
CARBOPLATIN, |
||||
761 | 25014417 |
HN |
53 | 2 |
Peripheral swelling, Drug hypersensitivity, Gait inability, Peripheral swelling, Burning sensation, Oedema peripheral, Blister, Blood blister, Blister, Product use issue, |
||||
SORAFENIB, SORAFENIB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, INSULIN GLARGINE, |
||||
762 | 25014973 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Coeliac disease, Condition aggravated, Confusional state, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event, Hospitalisation, |
||||
ABATACEPT, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOPIRAMATE, TOPIRAMATE, VITAMIN C, VITAMIN C, TOFACITINIB, TOFACITINIB, |
||||
763 | 25015062 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMLODIPINE BESYLATE, CALCIUM, CLONAZEPAM, ERGOCALCIFEROL, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, PREDNISONE, RITUXIMAB, ROSUVASTATIN CALCIUM, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, RISEDRONATE SODIUM, THEOPHYLLINE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, |
||||
764 | 25006975 |
US |
2 | |
Drug hypersensitivity, Dyspnoea, |
||||
SULFAMETHOXAZOLE AND TRIMETHOPRIM, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, TRIMETHOPRIM, AMIKACIN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CEFDINIR, CEFDINIR, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LITHIUM, LITHIUM BROMATUM, METOPROLOL TARTRATE, METOPROLOL, MIRTAZAPINE, RIFAMPIN, |
||||
765 | 25007024 |
US |
||
Drug hypersensitivity, |
||||
HEPARIN SODIUM, |
||||
766 | 25007327 |
CA |
||
C-reactive protein abnormal, C-reactive protein increased, Confusional state, Drug hypersensitivity, Dyspnoea, Ill-defined disorder, Infusion related reaction, Injection site reaction, Nausea, Onychomadesis, Onychomycosis, Pain, Pericarditis, Pemphigus, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Wound, Contraindicated product administered, Drug ineffective, Off label use, Product use issue, Product use in unapproved indication, Treatment failure, Therapeutic product effect decreased, Therapeutic product effect incomplete, Intentional product use issue, Intentional product use issue, Intentional product use issue, Overdose, Underdose, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, USTEKINUMAB, USTEKINUMAB, INFLIXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CANDESARTAN, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LAMOTRIGINE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NEOMYCIN SULFATE, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, THIAMINE HYDROCHLORIDE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, VITAMIN C, ERGOCALCIFEROL, TOFACITINIB, |
||||
767 | 25007854 |
US |
31 | 2 |
Injection site reaction, Drug hypersensitivity, |
||||
ETANERCEPT, |
||||
768 | 25007869 |
IT |
35 | 1 |
Macroglossia, Drug hypersensitivity, Urticaria, |
||||
DICLOFENAC SODIUM, |
||||
769 | 25007982 |
ES |
5 | 2 |
Drug hypersensitivity, |
||||
CISPLATIN, ETOPOSIDE, |
||||
770 | 25008070 |
US |
1 | |
Death, Drug hypersensitivity, Product use issue, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, METHADONE HYDROCHLORIDE, METHADONE, SERTRALINE HYDROCHLORIDE, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES 8.6 MG TABLETS, VENETOCLAX, ZONISAMIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PALBOCICLIB, |
||||
771 | 25008116 |
US |
||
Blood iron decreased, Drug hypersensitivity, Off label use, |
||||
CAPIVASERTIB, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
772 | 25008301 |
US |
2 | |
Drug hypersensitivity, |
||||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
773 | 25008305 |
US |
2 | |
Drug hypersensitivity, |
||||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
774 | 25008535 |
CA |
36 | 2 |
Coeliac disease, Psoriasis, Foetal death, Erythema, Fatigue, Pain, Bursitis, Intentional product misuse, Contraindicated product administered, Pyrexia, Overdose, Hepatic enzyme increased, Product use issue, Thrombocytopenia, Back pain, Off label use, Immunodeficiency, Drug intolerance, Exposure during pregnancy, Joint swelling, Hypertension, Infusion related reaction, Drug hypersensitivity, Hyperhidrosis, Headache, Food allergy, Asthma, Upper respiratory tract infection, Rash, Infection, Drug ineffective, Hypersensitivity, Fluid retention, Prescribed overdose, Temperature regulation disorder, Constipation, Rash erythematous, Rheumatoid arthritis, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, TEMAZEPAM, ABATACEPT, PROGESTERONE, LAMIVUDINE, LAMIVUDINE ORAL, MORPHINE SULFATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, MONTELUKAST SODIUM, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, PROGESTERONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, TOCILIZUMAB, FLUCONAZOLE, MOXIFLOXACIN HYDROCHLORIDE, RITUXIMAB, STANDARDIZED SENNA CONCENTRATE, INFLIXIMAB, SENNOSIDES, ETANERCEPT, FUROSEMIDE, ADALIMUMAB, PSYLLIUM HUSK, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ONDANSETRON HYDROCHLORIDE, ABACAVIR SULFATE, GABAPENTIN, MONTELUKAST SODIUM, MONTELUKAST, MEPERIDINE HYDROCHLORIDE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, BUPROPION HYDROCHLORIDE, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION, CYCLOBENZAPRINE, CYCLOBENZAPRINE, FLUTICASONE PROPIONATE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, PROGESTERONE, KETOPROFEN, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, BUPROPION HYDROCHLORIDE, CLONIDINE, CLONIDINE, SENNA LEAF, HYDROMORPHONE HYDROCHLORIDE, ALPRAZOLAM, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, DOLUTEGRAVIR SODIUM, |
||||
775 | 25009042 |
78 | 2 | |
Drug hypersensitivity, Angioedema, Swollen tongue, Lip swelling, Anaphylactic reaction, |
||||
TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, |
||||
776 | 25009438 |
US |
77 | 1 |
Drug hypersensitivity, |
||||
SOTAGLIFLOZIN, |
||||
777 | 25010042 |
31 | 2 | |
Sepsis, Drug hypersensitivity, |
||||
OMALIZUMAB, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, BUPROPION HYDROCHLORIDE, BUPROPION, OMEPRAZOLE, FAMOTODINE, ESOMEPRAZOLE MAGNESIUM, FAMOTIDINE, RANITIDINE HYDROCHLORIDE, KENALOG, MELOXICAM, FAMOTIDINE, DESVENLAFAXINE SUCCINATE, PROPRANOLOL HYDROCHLORIDE, UBROGEPANT, |
||||
778 | 25010060 |
US |
71 | 2 |
Toxicity to various agents, Cardiogenic shock, Right ventricular dysfunction, Lactic acidosis, Septic shock, Drug hypersensitivity, Arrhythmic storm, Bundle branch block right, Overdose, |
||||
MOLNUPIRAVIR, |
||||
779 | 25010192 |
US |
||
Drug hypersensitivity, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
780 | 25010309 |
CA |
43 | 2 |
Arthropathy, Injury, Breast cancer stage III, Confusional state, Depression, Dizziness, Drug hypersensitivity, Drug intolerance, Duodenal ulcer perforation, Dry mouth, Epilepsy, Facet joint syndrome, Fibromyalgia, Arthralgia, Folliculitis, Gait inability, Gastrooesophageal reflux disease, Glossodynia, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Asthenia, Impaired healing, Infusion related reaction, Infusion site reaction, Intentional product use issue, Irritable bowel syndrome, Liver function test increased, Lung disorder, Night sweats, Muscle injury, Muscle spasms, Anti-cyclic citrullinated peptide antibody positive, Muscular weakness, Musculoskeletal pain, Neck pain, Obesity, Onychomadesis, Nasopharyngitis, Osteoarthritis, Paraesthesia, Pemphigus, Peripheral swelling, Back injury, Abdominal pain upper, Peripheral venous disease, Pneumonia, Psoriatic arthropathy, Rheumatoid arthritis, Sleep disorder, Stomatitis, Synovitis, Systemic lupus erythematosus, Taste disorder, Blepharospasm, Therapeutic product effect decreased, Treatment failure, Urticaria, Type 2 diabetes mellitus, Wheezing, Wound infection, Blister, Bursitis, C-reactive protein increased, General physical health deterioration, Blood cholesterol increased, Inflammation, Joint swelling, Joint range of motion decreased, Hand deformity, Abdominal discomfort, Alopecia, Diarrhoea, Contraindicated product administered, Live birth, Drug ineffective, Product use in unapproved indication, Product quality issue, Maternal exposure during pregnancy, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CANDESARTAN, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, SECUKINUMAB, CYCLOBENZAPRINE, DICLOFENAC, DICLOFENAC SODIUM, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ERGOCALCIFEROL, AZELAIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, HYDROMORPHONE HYDROCHLORIDE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, AZATHIOPRINE, INFLIXIMAB, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, MAGNESIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHYLPREDNISOLONE, MINOCYCLINE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, MEPOLIZUMAB, OXYCODONE, ABATACEPT, APREMILAST, PANTOPRAZOLE, PHENYLEPHRINE HYDROCHLORIDE, PHOSPHORUS, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOFACITINIB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
781 | 25010328 |
CA |
43 | 2 |
Pancreatitis, Liver disorder, Systemic lupus erythematosus, Breast cancer stage III, Colitis ulcerative, Delirium, Dislocation of vertebra, Duodenal ulcer perforation, Pericarditis, Porphyria acute, Psoriatic arthropathy, Rectal haemorrhage, Rheumatoid arthritis, Wound infection, Therapy non-responder, Underdose, Abdominal discomfort, Blood cholesterol increased, Bursitis, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Decreased appetite, Depression, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Dry mouth, Fatigue, Feeling hot, Fibromyalgia, Frequent bowel movements, Gait disturbance, Grip strength decreased, Inflammation, Irritable bowel syndrome, Joint range of motion decreased, Laboratory test abnormal, Lip dry, Memory impairment, Mobility decreased, Muscle spasms, Muscular weakness, Musculoskeletal pain, Night sweats, Obesity, Oedema peripheral, Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Adverse drug reaction, Adverse event, Amnesia, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blister, Osteoarthritis, Pain in extremity, Paraesthesia, Peripheral venous disease, Rash, Rheumatoid factor positive, Road traffic accident, Sciatica, Swelling, Synovitis, Vomiting, Weight decreased, Weight increased, Wheezing, White blood cell count increased, Wound, Off label use, Intentional product misuse, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
782 | 25010426 |
US |
67 | 2 |
Drug hypersensitivity, Hepatic cirrhosis, Pathogen resistance, Therapy interrupted, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, LINEZOLID, OMADACYCLINE, PENICILLIN G SODIUM, |
||||
783 | 25010486 |
US |
67 | 2 |
Shock, Multiple organ dysfunction syndrome, Myocarditis, Cardiomyopathy, Drug hypersensitivity, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, BELIMUMAB, PREDNISONE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, |
||||
784 | 25010808 |
US |
||
Drug hypersensitivity, Swelling, Off label use, |
||||
SAPROPTERIN DIHYDROCHLORIDE, PEGVALIASE-PQPZ, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, GUAIFENESIN AND DEXTROMETHORPHAN, DEXTROMETHORPHAN HYDROBROMIDE,GUAIFENESIN, TOPIRAMATE, TOPIRAMATE, NAPROXEN, NAPROXEN SODIUM, SERTRALINE HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
785 | 25010958 |
CA |
78 | 2 |
Anaemia, Aspiration, Asthenia, Asthma, Blood calcium increased, Blood creatinine increased, Blood test abnormal, Bronchiectasis, Bronchopulmonary aspergillosis allergic, Constipation, Cough, Drug hypersensitivity, Drug ineffective, Dyspnoea, Fatigue, Gastrooesophageal reflux disease, Haemoptysis, Headache, Hypoxia, Liver function test increased, Lower respiratory tract infection, Lung opacity, Musculoskeletal stiffness, Obstructive airways disorder, Oedema peripheral, Pain, Pleural effusion, Pleuritic pain, Pneumonia, Product dose omission issue, Pulmonary fibrosis, Pulmonary mass, Pyrexia, Rales, Sputum discoloured, Total lung capacity decreased, Transaminases increased, Tremor, Upper respiratory tract infection, Wheezing, |
||||
MONTELUKAST SODIUM, MONTELUKAST SODIUM, MONTELUKAST SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, IPRATROPIUM BROMIDE, BUDESONIDE, CANDESARTAN, DEXLANSOPRAZOLE, NITROGLYCERIN, EFINACONAZOLE, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MORPHINE SULFATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PRAMIPEXOLE, PREGABALIN, QUETIAPINE FUMARATE, QUETIAPINE, RANITIDINE, RISEDRONATE SODIUM, ROSUVASTATIN, ALBUTEROL SULFATE, ALBUTEROL, SENNOSIDES, STANDARDIZED SENNA CONCENTRATE, LEVOTHYROXINE SODIUM, TRAZODONE HYDROCHLORIDE, |
||||
786 | 25011013 |
CA |
58 | 2 |
Cardiac failure, Asthma, Back pain, Bursitis, Coeliac disease, Constipation, Decreased immune responsiveness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Erythema, Exposure during pregnancy, Fatigue, Fluid retention, Foetal death, Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypertension, Hyponatraemia, Immunodeficiency, Infection, Infusion related reaction, Joint swelling, Nausea, Off label use, Overdose, Pain, Prescribed overdose, Product use issue, Psoriasis, Pyrexia, Rash, Rash erythematous, Retching, Rheumatoid arthritis, Temperature regulation disorder, Thrombocytopenia, Upper respiratory tract infection, |
||||
FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOCILIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, BUPROPION HYDROCHLORIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONIDINE, PROGESTERONE, MEPERIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DOLUTEGRAVIR SODIUM, ETANERCEPT, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
787 | 25011027 |
CA |
65 | 2 |
Pneumonia, Asthma, Drug hypersensitivity, Oedema, Dyspnoea, Vomiting, Wheezing, |
||||
FLUTICASONE PROPIONATE, OMALIZUMAB, PREDNISONE, RISEDRONATE SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMINOPHYLLINE, AMLODIPINE BESYLATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, HYDROMORPHONE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, MONTELUKAST SODIUM, TRAMADOL HYDROCHLORIDE, RITUXIMAB, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, MOXIFLOXACIN HYDROCHLORIDE, RISEDRONATE SODIUM, ROSUVASTATIN CALCIUM, |
||||
788 | 25012573 |
66 | 2 | |
Eye swelling, Myalgia, Drug hypersensitivity, |
||||
OMALIZUMAB, |
||||
789 | 25014388 |
|||
Drug hypersensitivity, |
||||
GABAPENTIN, |
||||
790 | 25001947 |
CN |
35 | 1 |
Arrhythmia, Heart rate increased, Erythema, Drug hypersensitivity, Flushing, Tachypnoea, |
||||
VITAMIN C, DEXTROSE MONOHYDRATE, DEXTROSE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
791 | 25001990 |
CA |
97 | 2 |
Abdominal discomfort, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Fatigue, Fibromyalgia, Fluid retention, Folliculitis, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, General symptom, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, Hospitalisation, Adverse event, Off label use, |
||||
ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LORAZEPAM, CALCIUM, CALCIUM CARBONATE, ANTACID, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, INFLIXIMAB, INFLIXIMAB, IODINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LANSOPRAZOLE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LISINOPRIL, LORAZEPAM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, APREMILAST, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, FISH OIL, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, ERGOCALCIFEROL, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
792 | 25002630 |
CA |
65 | 2 |
Wheezing, Oedema, Drug hypersensitivity, Pneumonia, Dyspnoea, Asthma, Vomiting, |
||||
RITUXIMAB, OMALIZUMAB, CLONAZEPAM, MONTELUKAST, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, AMLODIPINE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, AMINOPHYLLINE, ROSUVASTATIN, PREDNISOLONE SODIUM PHOSPHATE, TRAMADOL HYDROCHLORIDE, |
||||
793 | 25002791 |
US |
1 | |
Drug hypersensitivity, Abscess, Staphylococcal infection, General physical health deterioration, |
||||
ADALIMUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
794 | 25002841 |
US |
||
Drug hypersensitivity, |
||||
EPOETIN ALFA, |
||||
795 | 25002907 |
CA |
20 | 1 |
Drug hypersensitivity, Meningitis meningococcal, Vaccination failure, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, AZATHIOPRINE, BELIMUMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, ECULIZUMAB, PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM, |
||||
796 | 25003076 |
DE |
69 | 2 |
Shock symptom, Flushing, Bronchospasm, Hypotension, Type I hypersensitivity, Swelling face, Drug hypersensitivity, |
||||
CEFUROXIME, PROPOFOL, ROCURONIUM, ROCURONIUM BROMIDE, SUFENTANIL, |
||||
797 | 25003080 |
CA |
||
COVID-19, Eczema, Dermatitis infected, Drug hypersensitivity, Skin bacterial infection, Product substitution issue, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, CYANOCOBALAMIN, CYANOCOBALAMIN, |
||||
798 | 25003205 |
US |
||
Disability, Asthma, Drug hypersensitivity, Lung disorder, Dyspnoea exertional, Productive cough, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, |
||||
799 | 25003329 |
US |
2 | |
Drug hypersensitivity, Hyperkalaemia, Hospitalisation, Product administration error, Therapy interrupted, Eye pain, Ocular hyperaemia, Asthenia, Malaise, Pain, |
||||
CENEGERMIN-BKBJ, CENEGERMIN-BKBJ, CENEGERMIN-BKBJ, CENEGERMIN-BKBJ, CENEGERMIN-BKBJ, CENEGERMIN-BKBJ, CENEGERMIN-BKBJ, CENEGERMIN-BKBJ, VITAMIN C, VITAMIN C, CARBOXYMETHYLCELLULOSE SODIUM, DAPAGLIFLOZIN, CETIRIZINE HCL, CETIRIZINE, CLONAZEPAM, ALBUTEROL SULFATE, GLIPIZIDE, OFLOXACIN, OFLOXACIN OTIC, OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3%, OFLOXACIN OTIC SOLUTION, MAGNESIUM CARBONATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALENDRONATE SODIUM, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FISH OIL, MELOXICAM, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CALCIUM CARBONATE, TORSEMIDE, SPIRONOLACTONE, PREGABALIN, MORPHINE SULFATE, SERTRALINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, MAGNESIUM, |
||||
800 | 25003424 |
US |
32 | 2 |
Drug hypersensitivity, |
||||
METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28